David M. Rubenstein

Insider Reports History

Location
Washington, DC
Signature
/s/ Anne K. Frederick by power of attorney for David M. Rubenstein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David M. Rubenstein:

Company Role Class Num Shares Value Price $ Report Date Ownership
Carlyle Group Inc. Director Common Stock 27,999,644 $1,583,379,868 $56.55 10 Dec 2025 Direct
Moderna, Inc. Director Restricted Stock Units 0 $82,339 $121.62 05 Aug 2025 Direct
Moderna, Inc. Director Common Stock 1,527 $51,368 $33.64 05 Aug 2025 Direct
Moderna, Inc. Director Stock Option (Right to Buy) 12,756 30 Apr 2025 Direct

Insider Reports Filed by David M. Rubenstein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CG Carlyle Group Inc. 10 Dec 2025 2 -$35,343,750 4 Director 12 Dec 2025, 17:35
MRNA Moderna, Inc. 05 Aug 2025 2 $0 4 Director 06 Aug 2025, 16:06
MRNA Moderna, Inc. 30 Apr 2025 4 $0 4 Director 01 May 2025, 16:34
MRNA Moderna, Inc. 05 Aug 2024 4 $0 4 Director 07 Aug 2024, 16:06
MRNA Moderna, Inc. 05 Aug 2024 0 $0 3 Director 07 Aug 2024, 16:02
CG Carlyle Group Inc. 06 Jun 2022 1 -$77,340,000 4 Director 06 Jun 2022, 16:30
CG Carlyle Group Inc. 09 Nov 2021 1 -$116,000,000 4 Director 10 Nov 2021, 16:52
CG Carlyle Group Inc. 11 Aug 2021 3 -$188,391,088 4 Director 13 Aug 2021, 21:14
CG Carlyle Group Inc. 18 May 2021 1 -$83,520,000 4 Director, 10%+ Owner 19 May 2021, 18:15